329 related articles for article (PubMed ID: 17243056)
1. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality.
Upton A; Kirby KA; Carpenter P; Boeckh M; Marr KA
Clin Infect Dis; 2007 Feb; 44(4):531-40. PubMed ID: 17243056
[TBL] [Abstract][Full Text] [Related]
2. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.
Marr KA; Carter RA; Boeckh M; Martin P; Corey L
Blood; 2002 Dec; 100(13):4358-66. PubMed ID: 12393425
[TBL] [Abstract][Full Text] [Related]
3. Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes.
Parody R; Martino R; Sánchez F; Subirá M; Hidalgo A; Sierra J
Am J Hematol; 2009 Sep; 84(9):571-8. PubMed ID: 19676118
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers.
Cordonnier C; Ribaud P; Herbrecht R; Milpied N; Valteau-Couanet D; Morgan C; Wade A;
Clin Infect Dis; 2006 Apr; 42(7):955-63. PubMed ID: 16511759
[TBL] [Abstract][Full Text] [Related]
5. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning.
Fukuda T; Boeckh M; Carter RA; Sandmaier BM; Maris MB; Maloney DG; Martin PJ; Storb RF; Marr KA
Blood; 2003 Aug; 102(3):827-33. PubMed ID: 12689933
[TBL] [Abstract][Full Text] [Related]
6. Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center.
Fukuda T; Boeckh M; Guthrie KA; Mattson DK; Owens S; Wald A; Sandmaier BM; Corey L; Storb RF; Marr KA
Biol Blood Marrow Transplant; 2004 Jul; 10(7):494-503. PubMed ID: 15205670
[TBL] [Abstract][Full Text] [Related]
7. Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplant.
El-Cheikh J; Castagna L; Wang L; Esterni B; Faucher C; Fürst S; Pierre B; Mohty M; Blaise D
Leuk Lymphoma; 2010 Sep; 51(9):1705-10. PubMed ID: 20629522
[TBL] [Abstract][Full Text] [Related]
8. Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies.
Dib RW; Hachem RY; Chaftari AM; Ghaly F; Jiang Y; Raad I
BMC Infect Dis; 2018 Dec; 18(1):656. PubMed ID: 30545320
[TBL] [Abstract][Full Text] [Related]
9. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles.
Ramos ER; Jiang Y; Hachem R; Kassis C; Kontoyiannis DP; Raad I
Oncologist; 2011; 16(7):1049-60. PubMed ID: 21659609
[TBL] [Abstract][Full Text] [Related]
10. Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis.
Salmeron G; Porcher R; Bergeron A; Robin M; Peffault de Latour R; Ferry C; Rocha V; Petropoulou A; Xhaard A; Lacroix C; Sulahian A; Socié G; Ribaud P
Haematologica; 2012 Sep; 97(9):1357-63. PubMed ID: 22371177
[TBL] [Abstract][Full Text] [Related]
11. Combination antifungal therapy for invasive aspergillosis: a randomized trial.
Marr KA; Schlamm HT; Herbrecht R; Rottinghaus ST; Bow EJ; Cornely OA; Heinz WJ; Jagannatha S; Koh LP; Kontoyiannis DP; Lee DG; Nucci M; Pappas PG; Slavin MA; Queiroz-Telles F; Selleslag D; Walsh TJ; Wingard JR; Maertens JA
Ann Intern Med; 2015 Jan; 162(2):81-9. PubMed ID: 25599346
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with mortality in transplant patients with invasive aspergillosis.
Baddley JW; Andes DR; Marr KA; Kontoyiannis DP; Alexander BD; Kauffman CA; Oster RA; Anaissie EJ; Walsh TJ; Schuster MG; Wingard JR; Patterson TF; Ito JI; Williams OD; Chiller T; Pappas PG
Clin Infect Dis; 2010 Jun; 50(12):1559-67. PubMed ID: 20450350
[TBL] [Abstract][Full Text] [Related]
14. Invasive aspergillosis in hematopoietic stem cell transplant recipients: a retrospective analysis.
Carvalho-Dias VM; Sola CB; Cunha CA; Shimakura SE; Pasquini R; Queiroz-Telles Fd
Braz J Infect Dis; 2008 Oct; 12(5):385-9. PubMed ID: 19219277
[TBL] [Abstract][Full Text] [Related]
15. Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.
Rubio PM; Sevilla J; González-Vicent M; Lassaletta A; Cuenca-Estrella M; Díaz MA; Riesco S; Madero L
J Pediatr Hematol Oncol; 2009 Sep; 31(9):642-6. PubMed ID: 19684521
[TBL] [Abstract][Full Text] [Related]
16. Invasive aspergillosis and allogeneic hematopoietic stem cell transplantation in children: a 15-year experience.
Crassard N; Hadden H; Pondarré C; Hadden R; Galambrun C; Piens MA; Pracros JP; Souillet G; Basset T; Berthier JC; Philippe N; Bertrand Y
Transpl Infect Dis; 2008 Jun; 10(3):177-83. PubMed ID: 18331389
[TBL] [Abstract][Full Text] [Related]
17. Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients.
Choi SH; Kang ES; Eo H; Yoo SY; Kim JH; Yoo KH; Sung KW; Koo HH; Kim YJ
Pediatr Blood Cancer; 2013 Feb; 60(2):316-22. PubMed ID: 23042761
[TBL] [Abstract][Full Text] [Related]
18. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
Armenian SH; Nash KA; Kapoor N; Franklin JL; Gaynon PS; Ross LA; Hoffman JA
J Pediatr Hematol Oncol; 2009 Dec; 31(12):920-6. PubMed ID: 19855303
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients.
Cesaro S; Giacchino M; Locatelli F; Spiller M; Buldini B; Castellini C; Caselli D; Giraldi E; Tucci F; Tridello G; Rossi MR; Castagnola E
BMC Infect Dis; 2007 Apr; 7():28. PubMed ID: 17442100
[TBL] [Abstract][Full Text] [Related]
20. Improved survival over the last decade in pediatric patients requiring dialysis after hematopoietic cell transplantation.
Rajpal JS; Patel N; Vogel RI; Kashtan CE; Smith AR
Biol Blood Marrow Transplant; 2013 Apr; 19(4):661-5. PubMed ID: 23266833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]